Filing metadata

Accession number
0001470831-26-000214
Form type
Form 4
Filer
BridgeBio Pharma, Inc.
CIK
CIK 1743881
Filed
Feb 23, 2026
Reporting period
Feb 19, 2026
Description
Insider transaction

Explore SEC Filings Hub